13F Data
13F filer · CIK 1747821

Decheng Capital Management III (Cayman), LLC

Grand Cayman, E9 · filing since Q1 2022 · last filing Dec 12, 2023
Reported value
$299.6M
$-19.2M vs prior
Positions
26
New / sold out
9 / 8
Added / reduced
1 / 2
Turnover
31.8%
buys $135.9M · sells $98.2M
Top-10 weight
79.2%

Biggest buys vs Q2 2023

ChangeSecurityShares changeChange %Est. trade value
NewAlpine Immune Sciences, Inc.+6,708,288–+$76.8M
NewROIVANT SCIENCES LTD+1,459,700–+$17.0M
AddedAura Biosciences, Inc.+869,790+296.5%+$13.6M
NewLANTHEUS HOLDINGS INC(NMS)+142,196–+$9.9M
NewIMMUNOGEN INC+415,880–+$6.6M
NewSEAGEN INC+23,014–+$4.9M
NewBeyondSpring Inc.+4,958,143–+$4.0M
NewAtriCure Inc.+46,259–+$2.0M
NewPyxis Oncology, Inc (formerly Apexigen)+326,810–+$650.4K
NewGeneDx Holdings Corp.+103,604–+$377.1K

Biggest sells vs Q2 2023

ChangeSecurityShares changeChange %Est. trade value
Sold outAlpine Immune Sciences, Inc.-6,708,288-100.0%$-69.0M
Sold outROIVANT SCIENCES LTD-1,459,700-100.0%$-14.7M
Sold outBeyondSpring Inc.-4,958,143-100.0%$-5.9M
Sold outSeagen Inc.-23,014-100.0%$-4.4M
Sold outAtriCure Inc.-46,259-100.0%$-2.3M
Sold outApexigen, Inc.-1,894,551-100.0%$-814.3K
Sold outGeneDx Holdings Corp.-103,604-100.0%$-617.5K
ReducedAdicet Bio, Inc.-305,467-60.4%$-418.5K
Sold outNeuBase Therapeutics, Inc.-50,000-100.0%$-92.5K
ReducedACELYRIN INC(NSM)-6,100-0.4%$-62.0K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q1 2022: $326.3MQ2 2022: $263.7MQ3 2022: $275.8MQ4 2022: $267.2MQ1 2023: $247.9MQ2 2023: $318.8MQ3 2023: $299.6M
Q1 2022Q3 2023

Holdings · Q3 2023

#SecuritySharesValueWeight
1Alpine Immune Sciences, Inc.COM6,708,288$76.8M25.63%
2Zentalis Pharmaceuticals Inc.COM2,099,583$42.1M14.06%
3Aura Biosciences, Inc.COM1,163,123$18.2M6.09%
4ROIVANT SCIENCES LTDCOM1,459,700$17.0M5.69%
5ACELYRIN INC(NSM)COM1,548,317$15.7M5.26%
6Arcus Biosciences, IncCOM869,790$15.6M5.21%
710x Genomics, Inc.CL A COM359,554$14.8M4.95%
8Argenx SESHS27,429$13.5M4.50%
9Pacific Biosciences of California, Inc.COM1,463,872$12.2M4.08%
10Illumnia, Inc.COM80,859$11.1M3.70%
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.